Does MEGLUMINE Cause Mobility decreased? 226 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 226 reports of Mobility decreased have been filed in association with MEGLUMINE. This represents 38.6% of all adverse event reports for MEGLUMINE.
226
Reports of Mobility decreased with MEGLUMINE
38.6%
of all MEGLUMINE reports
224
Deaths
219
Hospitalizations
How Dangerous Is Mobility decreased From MEGLUMINE?
Of the 226 reports, 224 (99.1%) resulted in death, 219 (96.9%) required hospitalization, and 220 (97.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 226 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which MEGLUMINE Alternatives Have Lower Mobility decreased Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE